(19)
(11) EP 3 856 229 A1

(12)

(43) Date of publication:
04.08.2021 Bulletin 2021/31

(21) Application number: 19779012.4

(22) Date of filing: 30.09.2019
(51) International Patent Classification (IPC): 
A61K 38/20(2006.01)
C07K 14/715(2006.01)
A61K 39/00(2006.01)
A61P 35/00(2006.01)
C07K 16/28(2006.01)
(86) International application number:
PCT/EP2019/076471
(87) International publication number:
WO 2020/065096 (02.04.2020 Gazette 2020/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 28.09.2018 US 201862738391 P
19.03.2019 EP 19305336

(71) Applicant: PIERRE FABRE MEDICAMENT
92100 Boulogne-Billancourt (FR)

(72) Inventors:
  • LOWE, Peter
    01300 CHAZEY BONS (FR)
  • HAEUW, Jean-François
    74160 BEAUMONT (FR)
  • CONTET, Alicia
    74160 SAINT JULIEN EN GENEVOIS (FR)
  • BERTAUX, Céline
    74580 VIRY (FR)
  • AKLA, Barbara
    74350 CRUSEILLES (FR)
  • JANIN-BUSSAT, Marie-Claire
    74160 SAINT JULIEN EN GENEVOIS (FR)

(74) Representative: Regimbeau 
20, rue de Chazelles
75847 Paris Cedex 17
75847 Paris Cedex 17 (FR)

   


(54) NEW IMMUNOCYTOKINES FOR THE TREATMENT OF CANCER